First Time Loading...
P

Porton Pharma Solutions Ltd
SZSE:300363

Watchlist Manager
Porton Pharma Solutions Ltd
SZSE:300363
Watchlist
Price: 16.81 CNY -1.7% Market Closed
Updated: May 5, 2024

Wall Street
Price Targets

Price Targets Summary
Porton Pharma Solutions Ltd

Wall Street analysts forecast Porton Pharma Solutions Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Porton Pharma Solutions Ltd is 27.18 CNY with a low forecast of 20.5 CNY and a high forecast of 34.65 CNY.

Lowest
Price Target
20.5 CNY
22% Upside
Average
Price Target
27.18 CNY
62% Upside
Highest
Price Target
34.65 CNY
106% Upside
Porton Pharma Solutions Ltd Competitors:
Price Targets
326030
SK Biopharmaceuticals Co Ltd
29% Upside
OFSA3
Ouro Fino Saude Animal Participacoes SA
12% Upside
ANIP
ANI Pharmaceuticals Inc
21% Upside
WEED
Canopy Growth Corp
52% Downside
600521
Zhejiang Huahai Pharmaceutical Co Ltd
0% Downside
NOVO B
Novo Nordisk A/S
8% Upside
ETON
Eton Pharmaceuticals Inc
175% Upside
4569
Kyorin Holdings Inc
3% Downside

Revenue
Forecast

Revenue Estimate
Porton Pharma Solutions Ltd

For the last 8 years the compound annual growth rate for Porton Pharma Solutions Ltd's revenue is 28%. The projected CAGR for the next 4 years is -11%.

28%
Past Growth
-11%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Porton Pharma Solutions Ltd

For the last 8 years the compound annual growth rate for Porton Pharma Solutions Ltd's operating income is 40%. The projected CAGR for the next 4 years is -41%.

40%
Past Growth
-41%
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Porton Pharma Solutions Ltd

For the last 8 years the compound annual growth rate for Porton Pharma Solutions Ltd's net income is 41%. The projected CAGR for the next 3 years is -27%.

41%
Past Growth
-27%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Porton Pharma Solutions Ltd's stock price target?
Price Target
27.18 CNY

According to Wall Street analysts, the average 1-year price target for Porton Pharma Solutions Ltd is 27.18 CNY with a low forecast of 20.5 CNY and a high forecast of 34.65 CNY.

What is Porton Pharma Solutions Ltd's Revenue forecast?
Projected CAGR
-11%

For the last 8 years the compound annual growth rate for Porton Pharma Solutions Ltd's revenue is 28%. The projected CAGR for the next 4 years is -11%.

What is Porton Pharma Solutions Ltd's Operating Income forecast?
Projected CAGR
-41%

For the last 8 years the compound annual growth rate for Porton Pharma Solutions Ltd's operating income is 40%. The projected CAGR for the next 4 years is -41%.

What is Porton Pharma Solutions Ltd's Net Income forecast?
Projected CAGR
-27%

For the last 8 years the compound annual growth rate for Porton Pharma Solutions Ltd's net income is 41%. The projected CAGR for the next 3 years is -27%.